In silico studies on the interaction between bioactive ligands and DPP-IV: insights on potential candidates for the treatment of type 2 diabetes mellitus.

CONCLUSIONS: Therefore, from this study it is possible to propose molecular modifications of these DPP-IV inhibitors in order to improve their potential to treat type 2 diabetes. PMID: 31995015 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31995015?dopt=Abstract

Source: Medicinal Chemistry - January 28, 2020 Category: Chemistry Authors: Martins MCMR, Pantaleao SQ, de Oliveira Almeida M, Weber KC, Honorio KM Tags: Med Chem Source Type: research